test

Raymond Debbane

@Siren, L.l.c.

Latest period2024 - Q3ReportedManaged Assets$2BTotal holdings110
Assets growth rate0%Assets growth rate (2-Q avg)0%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Siren, L.l.c.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 110 positions.

Assets under management

The assets under management (AUM) of Siren, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2B in assets, with a quarterly growth rate of 0% and a 2-quarter average growth rate of 0%. The portfolio is managed by Raymond Debbane, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CNTACentessa Pharmaceuticals Plc
Recent Activity
New Position
2.61%
$52.106M
3.259M shares@ $15.99 avg price
ASNDAscendis Pharma A S
Recent Activity
New Position
2.6%
$51.948M
347,921 shares@ $149.32 avg price
SLNSilence Therapeutics Plc
Recent Activity
New Position
2.58%
$51.482M
2.832M shares@ $18.19 avg price
ARWRArrowhead Pharmaceuticals Inc
Recent Activity
New Position
2.39%
$47.627M
2.459M shares@ $19.38 avg price
WVEWave Life Sciences Ltd
Recent Activity
New Position
2.35%
$46.914M
5.721M shares@ $8.2 avg price
SWTXSpringworks Therapeutics Inc
Recent Activity
New Position
2.21%
$44.142M
1.378M shares@ $32.04 avg price
DYNDyne Therapeutics Inc
Recent Activity
New Position
2.04%
$40.757M
1.135M shares@ $35.93 avg price
VERAVera Therapeutics Inc
Recent Activity
New Position
1.86%
$37.036M
837,928 shares@ $44.21 avg price
NMRANeumora Therapeutics Inc
Recent Activity
New Position
1.73%
$34.433M
2.607M shares@ $13.22 avg price
PCVXVaxcyte Inc
Recent Activity
New Position
1.72%
$34.28M
299,991 shares@ $114.28 avg price